MedDataX Logo

Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia

NCT ID: NCT07312487

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-26

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inadequate analgesia during cesarean section is a common condition, notably addressed by national recommendations from the SFAR (French Society of Anesthesia and Intensive Care) in 2021.

The objective of this study is to identify the specific characteristics of this condition in Strasbourg in terms of risk factors and management, and then to propose a protocol for its prevention and management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia, Cesarean

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Analgesia During Cesarean Spinal Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult woman (age ≥18 years)
* Giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital

Exclusion Criteria

* Patient who has expressed her opposition to the reuse of her data for scientific research purposes.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'Anesthésie Réanimation médecine Péri-Opératoire - Hôpitaux Universitaires de Strasbourg

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stefanie KOESSLER, MD

Role: CONTACT

Phone: 33 3 88 12 70 90

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stefanie KOESSLER, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9379

Identifier Type: -

Identifier Source: org_study_id